Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment

BACKGROUND: Eculizumab is approved for atypical hemolytic uremic syndrome (aHUS). Guidelines discuss the importance of prompt treatment. We report a post hoc analysis investigating the effect of baseline factors, including patient characteristics and time from the latest aHUS manifestation to eculiz...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Nephrol
Main Authors: Walle, Johan Vande, Delmas, Yahsou, Ardissino, Gianluigi, Wang, Jimmy, Kincaid, John F., Haller, Herman
Format: Artigo
Sprog:Inglês
Udgivet: Springer International Publishing 2016
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5316393/
https://ncbi.nlm.nih.gov/pubmed/26995002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40620-016-0288-3
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker